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Curing HIV: A New Scientific Priority
One of the defining qualities of living with HIV has been that it is incurable, and this basic
fact has powerfully formed and disrupted individual, organizational, and institutional
identities [1, 2]. But now this basic fact is contested. Today one individual appears to be
cured [3, 4]. Several individuals are “post-treatment controllers,” having undetectable viral
loads following a period of early antiretroviral therapy [5, 6]. HIV cure research, once
unimaginable, is now at the center of public and scientific attention [7]. Curing HIV has
become a strategic priority of the International AIDS Society and the National Institute of
Allergy and Infectious Diseases at the US National Institutes of Health, spurring the
development of global HIV cure collaborations and advancing initial clinical research efforts
[8]. On both clinical and public health grounds, the identification of an effective HIV cure
would be a great achievement. It could decrease morbidity and mortality associated with
HIV infection, paving the way for comprehensive public health control efforts. At the same
time, curing HIV is best conceived not simply as an absolute medical victory, but also as a
social intervention whose meaning and effects are complex and uncertain.
Intended and Unintended Implications of Cure Research
History demonstrates that the social meaning of a disease – including how it is represented
and policies pertaining to its treatment and control – changes dramatically when advances in
biomedical research transforms it from incurable to treatable or even curable [9]. Research
efforts aspire to the development of effective curative interventions that can be widely
implemented in order to significantly reduce the burden of HIV infection. But new disease
cures are rarely linear advancements. They are often contested and accompanied by a
diversity of unintended consequences. While a completely effective and affordable cure
could emerge and contribute to global HIV control, alternatively HIV cure research efforts
might fail, leading to distrust and suspicion of researchers and public health authorities
among HIV-infected individuals and the general public. Or a cure may be only partially
effective or accessible to only a subset of HIV-infected individuals, raising questions of
justice and equity. While the history of infectious diseases provides examples of disease
eradication (e.g., smallpox), it is also rich with examples of cures, such as those for
tuberculosis or syphilis, where the development of a new cure has complex effects on
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overall disease control. A more comprehensive understanding of the social context of curing
HIV is fundamental to informing the logistics and implementation of research and programs
[10].
Social and Ethical Analyses in HIV Cure Research
Given the complexity of curing diseases generally, and HIV in particular, a comprehensive
social and ethical analysis is needed to accompany clinical cure research. Uncertainties
about the scientific and social meaning of HIV cure research underline the need to conduct
research that is both theoretical and empirical (Table 1). A proactive and multidisciplinary
exploration of the social dimensions of an HIV cure can inform the conduct of clinical
research studies and perhaps help to ensure that an HIV cure is accurately perceived and
appropriately implemented. Conceptual, historical, and ethical analyses of HIV cure
research are all important next steps that are briefly described below.
Conceptual analysis of HIV cure research
“Conceptual analysis” is branch of philosophy that examines concepts as holistic entities
and constituent parts in order to better understand them [11]. It has great relevance to
understanding the concept of an HIV cure. As a starting point, the broader concept of cure is
embedded in the history, culture, and sociology of disease. Cure is defined in the Oxford
English Dictionary as “to heal (a disease or wound)” or figuratively to “remedy, rectify, or
remove (an evil of any kind)” [12]. This second definition implies that the process of cure is
a complete removal of disease from the body, an absolute act that leaves the individual free
of both symptoms and the pathogen itself. Two things are notable about this concept: its
unambiguous positive trajectory (e.g., the idiom “to kill or cure” which means a way of
solving a problem that will either fail completely or be very successful) and its finality. Cure
is the terminus of physical abnormalities along the trajectory of illness. In this light, cure is
inherently aspirational. However, while HIV cure is an appropriate long-term goal and
strategic priority, there are many short-term and medium-term goals that will be necessary to
achieve in order to develop a cure. A functional cure, defined as symptom control without
viral elimination, or post-treatment control may be easier to achieve compared to a complete
sterilizing cure. Further development of HIV reservoir biomarkers and animal models are
necessary in order to clearly draw the boundaries between these new categories and assess
the need for structured treatment interruptions.
Historical analysis of HIV cure research
The historical experience of HIV and cures for other infectious diseases such as syphilis [13]
may provide insight into the social context of HIV cure research. HIV cure research could
give rise to speculation, distrust and confusion in locations such as South Africa [14],
Zambia [14], Zimbabwe [14], the Gambia [15], and Nigeria [16], where purported HIV
cures have been discredited in the past. On a positive note, unsuccessful HIV cures reveal
how HIV cure projects, even small trials and individual cases, can rapidly raise hopes and
galvanize communities [15]. History suggests that efforts to cure sexually transmitted
diseases may also result in unexpected synergies. For example, the momentum generated by
a new cure for syphilis (penicillin) during the 1940s spilled over into strengthening syphilis
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laboratory, diagnostic, and clinical capacity, setting the stage for several large-scale syphilis
control programs [17].
Ethics and HIV cure research
The pursuit of HIV cure research raises a number of important ethical issues [18, 19].
Human research studies on curing HIV introduce ethical challenges related to assessing and
communicating the risks and benefits of the research, challenges in participant selection, and
therapeutic misconception. First, our understanding of the risks and benefits of individual
participation in clinical HIV cure research is rapidly evolving. Small human studies limit the
extent to which generalizations can be made about curing HIV. Such early trials may pose
serious risks while initially producing little individual or social benefit. Standardized
guidelines on how to explain the complexities of HIV cure research to a general audience
are needed. Second, participant selection in early HIV cure research raises specific issues of
beneficence and justice. Similar to antiretroviral treatment research [20], early trials are
likely to involve white, non-marginalized, relatively affluent members of high-income
nations and be optimized within those health systems. Access to promising studies or
successful cure interventions would likely be available to lower income communities or
countries only gradually over time. Finally, therapeutic misconception may be especially
prominent in HIV cure research. Therapeutic misconception refers to “when individuals do
not understand that the defining purpose of clinical research is to produce generalizable
knowledge, regardless of whether the subjects enrolled in the trial may potentially benefit
from the intervention under study or from other aspects of the clinical trial” [21]. Cure
studies may be marked by a curative misconception among those who are HIV-infected and
who hope to permanently rid their bodies of the virus.
Sociological/Normative Analysis
Normative analysis is an investigation of what ought to happen, drawing on theoretical
constructs and value propositions. One potentially useful theory in considering HIV cure
research is Merton’s theory of “unanticipated consequences of purposive social action” [22].
This sociological theory proposes that social actions could have unintended negative
consequences in addition to their desired effects, negative consequences that perversely
relate to the desired effects, or unintended positive consequences. This theoretical
foundation could provide a richer understanding of the potential implications of HIV cure
research. For example, HIV organizations that have exclusively provided HIV services
without integration into local health systems may resist the growing momentum to consider
curing HIV. Although HIV is increasingly perceived as just another disease, many jobs,
careers, and identities are tightly linked with the service structures and research spawned by
HIV [23]. At the institutional level, implementation structures that establish a false
dichotomy between treatment and cure, similar to the false dichotomy between HIV
treatment and prevention in the 1990s [24], could pit these potentially complementary
approaches against each other. HIV cure implementation structures that identify individuals
with acute HIV infection have inherent public health benefits, but HIV cure research and
programs that depend on newly HIV-infected babies could introduce perverse incentives that
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are misaligned with global expectations regarding the elimination of mother-to-child HIV
transmission.
Conclusion
Thirty years ago, AIDS was a death sentence with no effective medical forms of prevention,
treatment, or cure. Its high morbidity, mortality and association with stigmatized sexual and
drug-use behaviors led to the rise of HIV exceptionalism, the tendency to treat HIV
differently from other diseases. While this arguably was justifiable early in the epidemic [2],
over time, a culture of HIV exceptionalism has profoundly shaped public perceptions, law,
policy, advocacy, funding priorities, and the structure of health service delivery. How curing
HIV either facilitates or hinders the integration of HIV services into routine health systems
requires both empirical and theoretical investigation. As a society, we must insist that
careful consideration, broad discussion, and clear communication surround the challenges
and expectations, benefits and costs, and social and ethical implications of the work to find a
cure for HIV.
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Table 1
Social and Ethical Considerations for HIV Cure Research
Cure Research Theme Analyses Key Research Questions
Theoretical Research Conceptual What is the operational definition of “cure” and other key terms such as “post-treatment
controllers”1?
Historical How are previous disease cures relevant or not to curing HIV? What were important
positive and negative consequences of efforts to cure other disease? How can history
inform our understanding of curing HIV?
Ethical What are best ways to assess and convey the uncertain risks and benefits of cure HIV
research? What are fair mechanisms to choose sites and participants? How can
therapeutic misconception be minimized?
Sociological/Normative What is an appropriate theoretical framework to inform HIV cure research? How
should cure research affect policy positions regarding HIV treatment and prevention?
Empirical Research Policy Who are the key policy stakeholders involved in HIV cure research? What are their
perceptions of potential positive and negative implications of curing HIV?
Anthropological How do HIV-infected individuals, HIV physicians, and others understand treatment
interruptions, risks and benefits, and other components of cure HIV research?
Community Engagement What media can be used to enhance conventional community engagement regarding
HIV cure research projects?
1
Term used in the VISCONTI trial to refer to individuals who received early HIV treatment and viral load remains undetectable off therapy[6].
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